Correlation Between Virpax Pharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Virax Biolabs.
Diversification Opportunities for Virpax Pharmaceuticals and Virax Biolabs
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and Virax is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, Virpax Pharmaceuticals is 1.16 times less risky than Virax Biolabs. The stock trades about 0.0 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 233.00 in Virax Biolabs Group on August 26, 2024 and sell it today you would lose (32.00) from holding Virax Biolabs Group or give up 13.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| Virax Biolabs Group |
Virpax Pharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Virpax Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Virpax Pharmaceuticals vs. Revelation Biosciences | Virpax Pharmaceuticals vs. Palisade Bio | Virpax Pharmaceuticals vs. Virax Biolabs Group | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Transaction History View history of all your transactions and understand their impact on performance |